v3.26.1
Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Recognized Stock-Based Compensation

The Company recognized stock-based compensation expense (options and restricted share grants) in its condensed consolidated statements of operations as follows:

 

   2026   2025 
   Three Months Ended March 31, 
   2026   2025 
Research and Development  $   $85 
General and Administrative   113    230 
Total  $113   $315 
Schedule of Stock Option Activity

The following table summarizes the activity for Company’ stock options for the three months ended March 31, 2026:

 

   Stock Options 
Outstanding at December 31, 2025   457,219 
Granted    
Exercised    
Forfeited   (12,449)
Expired   (8,302)
Outstanding at March 31, 2026   436,468